
Hers Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: women who want brand-name GLP-1s only, including the Wegovy pill and Foundayo, with a Hers membership
Hers scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Price checked on Hers’s site,
What the monthly price covers
Medication
Included
Provider visits
Billed separately
Shipping
Not stated
Lab work
Not stated
Coaching
Billed separately
No insurance needed · Vetted by our editors
Women-focused telehealth brand from Hims and Hers. As of August 2026 it sells only brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro and the new Foundayo pill, from $149/mo for medication) and no longer offers a compounded option. Every price excludes a mandatory Hers Weight Loss Membership at $149/mo after a $39 first month.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
What is Hers?
Hers is the women's telehealth brand from Hims & Hers, where licensed providers can prescribe brand-name GLP-1s such as the Wegovy pill, Wegovy pen, Zepbound and Foundayo after an online intake. Every plan runs through a Hers Weight Loss Membership, which adds 24/7 messaging with your care team, in-app tracking and a smart scale. It suits women who want FDA-approved medication without dealing with insurance.
Vetted alternatives to Hers
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Hers at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Zepbound, Ozempic
- Starting price
- $149/mo (+ required membership)
- What's included
- Medication
- FDA status
- 1 FDA warning letter on record; see below
How we scored Hers
Each dimension is scored algorithmically from Hers’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.4/10Hers' brand-name medication starts at $149/mo, with a required membership or program fee billed on top. Its value score is measured against the $179 median for GLP-1 providers, which compounded programs set, so brand-name sellers score lower on value by design.
Effectiveness25%
8.8/10Hers offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. It prescribes FDA-approved brand-name medication rather than compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.5/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
5.6/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
6.4/10Hers's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.8/10Coaching not included in the base price.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Hers review
Last checked October 2026- Confirmed current pricing across 10 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$1,899/mo across 10 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with Hers
We walked Hers’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Start online and complete a weight-loss intake/questionnaire.
- 2A licensed healthcare provider reviews eligibility and clinical criteria.
- 3If prescribed, an active Hers Weight Loss Membership is required and medication ships to you.
- 4Membership auto-renews and is billed separately from medication.
- Full medication price menu (Wegovy, Ozempic, Zepbound, Mounjaro, oral options) is visible before intake, but prices are 'medication only.'
- A separate mandatory membership ($39 first month, auto-renews at $149/mo) is required; 'medication is not available without a membership' and membership 'does not guarantee a prescription.'
- Brand-name GLP-1s only (no compounded).
- A video or audio visit may be required depending on your state.
- Auto-renewing membership; the first month's fee is non-refundable and canceling it also cancels your medication plan.
GLP-1 medications Hers offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149. This is the microdosing tier.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149. Hers labels this option 'New'.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149. Hers labels this option 'New'.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149. This is a separate, far more expensive tier than the $299 Zepbound Vial and KwikPen.
Medication only. A Hers Weight Loss Membership is required on top ($39 the first month, then $149/mo), and Hers states plainly that 'Medication is not available without a membership', so the all-in standing cost is this figure plus $149. This is a separate tier from the $299 Zepbound Vial and KwikPen.
Ready to get started?
Plans and promotions change often, so check Hers's current pricing and active discounts before you decide.
What we like
- Wide brand-name lineup: Wegovy pill and pen, Ozempic pill and pen, Zepbound, Mounjaro and the Foundayo pill
- Medication prices listed upfront, from $149/mo for the Wegovy, Ozempic and Foundayo pills
- Membership includes 24/7 messaging with licensed providers and dose adjustments in the app
- Generic Zofran included at no extra cost if prescribed, to help with nausea
- Smart scale included with the membership
- No insurance required
Watch-outs
- Every advertised price is medication-only; a mandatory $149/mo membership is billed separately on top
- No compounded option; brand-name medication only, so the cheapest all-in route is $298/mo
- The first month's $39 membership fee is non-refundable, and medication can't be refunded once it ships
- GLP-1s aren't available in all 50 states yet, and Hers doesn't publish the list
Hers: the women-focused face of a telehealth giant
Hers is the women's brand of Hims & Hers, one of the largest direct-to-consumer telehealth companies in the country. That lineage is the whole story here. You are not signing up with a scrappy weight-loss startup that might vanish in a year; you are getting a polished, mainstream platform with a national footprint, a recognizable name, and the kind of slick onboarding most patients already expect from a consumer health app. For a lot of people, that brand reassurance is exactly what they want when they start a semaglutide program. The trade-off is that Hers is built for the mass market, not for someone who wants to interrogate the fine print before they commit.
How the pricing works (and why one number isn't the whole picture)
On paper, Hers lists medication starting at $149 a month (+ required membership), but that headline is not the full cost. The advertised figure covers medication only, if you are prescribed it. Underneath that sits a separate Hers Weight Loss Membership that is billed on its own. It starts at a low introductory rate for the first month, then auto-renews at a much higher monthly fee. Hers lists that renewal at $149 a month, and you keep paying it for as long as you stay on the program. Compare that all-in total, not the headline, with our category median of $179.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
In other words, the monthly outlay is the medication line plus the membership line, and the membership is where the consult and the ongoing clinical support live. Hers does not bundle the visit or coaching into the medication price the way some competitors do. Medication is included; the consult and coaching are not. Budget for both charges, and watch that first-month teaser membership rate, because the renewal is several times higher.
- Medication line: $149/month (+ required membership) starting price, medication only
- Membership line: billed separately: a low first-month rate, then a much higher recurring monthly fee
- Not included in the headline number: the provider visit and ongoing coaching sit inside the membership, not the medication price
What you're getting in the bottle
Hers now sells brand-name GLP-1s only and no longer offers a compounded option. PreventiveMD still offers both, selling brand-name drugs alongside compounded plans priced all-in at every dose. The menu covers the Wegovy pill (including a microdosing plan) and Wegovy pen, which are semaglutide; the Ozempic pill and Ozempic; Zepbound vials, KwikPens and a separate higher-priced Zepbound tier, plus Mounjaro, which are tirzepatide; and the Foundayo pill. The cheapest options are the pills, listed from $149 a month (+ required membership) for medication alone. A provider decides which option, if any, fits your health history, so confirm the exact medication, dose, and delivery format on the checkout screen before you pay.
Nationwide reach, with an asterisk
Hims & Hers is a national brand, and that scale is an advantage. The platform itself is not accessible in Puerto Rico, and more importantly, Hers says its GLP-1s are not yet available in all 50 states. It doesn't publish a state list, so the weight-loss program may not be live in your state even though Hers as a brand is. The fix is simple: run your state and ZIP through the intake flow before you get attached to the price. This is the same nationwide-reach-with-fine-print pattern you will see across big telehealth brands. Our scoring methodology explains how we weigh access.
What sets Hers apart
Hers stands out for its consumer experience and the trust that comes with a household name, more than for its medication or its price. Hers nails the parts that intimidate first-time GLP-1 patients: a clean app, a familiar brand, a membership that wraps the clinical relationship into one tidy subscription, and the comfort of going with a company that is publicly traded and not going anywhere. If you have been putting off starting because the whole category feels sketchy or hard to navigate, Hers lowers that barrier better than almost anyone.
What it does not offer is transparency for the detail-oriented shopper. Hers publishes little about the program's inner workings. The pharmacy partners, the specifics of clinical oversight, and the full program terms are not laid out the way the most disclosure-forward providers do it. You are trusting the brand rather than auditing the operation.
Who should choose Hers, and who should skip it
Choose Hers if you want mainstream, low-friction GLP-1 access from a name you already recognize, you value a smooth app experience over granular control, and you are comfortable paying a separate membership for the clinical side. It is a sensible default for someone who just wants to get started without overthinking it.
Skip Hers if you are price-sensitive and want one all-in number, because the medication-plus-membership structure can add up once that first-month rate renews. Skip it too if you want to see exactly which pharmacy fills your prescription, what the accreditation looks like, and every line of the program terms before you pay. Hers keeps more of that behind the curtain than the most transparent competitors. Our ranking of semaglutide providers for women lines up the alternatives and also covers the cycle, birth-control and pregnancy-timing questions women tend to ask first.
Trust, safety, and medical oversight
On the safety ledger: Hers has an FDA warning letter on file, covered in the regulatory notice below. It does operate as part of a large, scrutinized public company, which brings a level of corporate accountability smaller players lack. The gap is disclosure. Hers publishes no pharmacy partner or accreditation detail for the weight-loss program. You are trusting the brand's scale, not a named supply chain. If pharmacy accreditation is a dealbreaker for you, ask Hers directly before you start and get the answer in writing.
The bottom line
Hers is a strong pick for mainstream telehealth GLP-1 access: trusted brand, national footprint, easy onboarding, and brand-name GLP-1 medication from $149 a month (+ required membership). Just go in clear-eyed about two things. The full cost is the medication plus a separate, auto-renewing membership, and the program details are thinner than what the most transparent providers publish. Confirm your state, confirm the exact formulation at checkout, and total up both charges before you commit. Do that, and Hers is a perfectly reasonable, low-stress way to begin.
The Bottom Line
Hers scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Hers?
From $149/mo (+ required membership). See current pricing and start your free consultation.
Hers might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Hers vs…
Hers scores7.5/10
Side-by-side pricing, medications and scores. Pick a matchup.
Hers vs Amazon One Medical
Amazon One Medical scores 8.5/10

Hers vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Hers received an FDA warning letter dated September 9, 2025
The letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Hers review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Hers's current pricing
Plans from $149/mo (+ required membership). Start your free consultation to check eligibility and today's price.